I agree that this site is using cookies. You can find further informations here.
X
Bailly, Fabrice
337  results:
OpenAccess-fulltext X
english X
?
1

Dynamics of quasi-steady ponded infiltration under contrast..:

Vinatier, Fabrice ; Rudi, Gabrielle ; Coulouma, Guillaume..
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.still.2023.105985.  , 2024
Link: https://hal.science/hal-..
 
?
2

Dynamics of quasi-steady ponded infiltration under contrast..:

Vinatier, Fabrice ; Rudi, Gabrielle ; Coulouma, Guillaume..
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.still.2023.105985.  , 2024
Link: https://hal.science/hal-..
 
?
3

Dynamics of quasi-steady ponded infiltration under contrast..:

Vinatier, Fabrice ; Rudi, Gabrielle ; Coulouma, Guillaume..
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.still.2023.105985.  , 2024
Link: https://hal.science/hal-..
 
?
4

Dynamics of quasi-steady ponded infiltration under contrast..:

Vinatier, Fabrice ; Rudi, Gabrielle ; Coulouma, Guillaume..
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.still.2023.105985.  , 2024
Link: https://hal.science/hal-..
 
?
5

Dynamics of quasi-steady ponded infiltration under contrast..:

Vinatier, Fabrice ; Rudi, Gabrielle ; Coulouma, Guillaume..
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.still.2023.105985.  , 2024
Link: https://hal.science/hal-..
 
?
6

Dynamics of quasi-steady ponded infiltration under contrast..:

Vinatier, Fabrice ; Rudi, Gabrielle ; Coulouma, Guillaume..
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.still.2023.105985.  , 2024
Link: https://hal.science/hal-..
 
?
7

Use of 2,6-diaminopurine as a potent suppressor of UGA prem..:

Leroy, Catherine ; Spelier, Sacha ; Essonghe, Nadège Charlene...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ymthe.2023.01.014.  , 2023
Link: https://hal.science/hal-..
 
?
8

Axicabtagene ciloleucel as second-line therapy in large B c..:

Houot, Roch ; Bachy, Emmanuel ; Cartron, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02572-5.  , 2023
Link: https://hal.science/hal-..
 
?
9

Axicabtagene ciloleucel as second-line therapy in large B c..:

Houot, Roch ; Bachy, Emmanuel ; Cartron, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02572-5.  , 2023
Link: https://hal.science/hal-..
 
?
10

Axicabtagene ciloleucel as second-line therapy in large B c..:

Houot, Roch ; Bachy, Emmanuel ; Cartron, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02572-5.  , 2023
Link: https://hal.science/hal-..
 
?
11

Axicabtagene ciloleucel as second-line therapy in large B c..:

Houot, Roch ; Bachy, Emmanuel ; Cartron, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02572-5.  , 2023
Link: https://hal.science/hal-..
 
?
12

S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LA..:

Roch Houot ; Emmanuel Bachy ; Guillaume Cartron...
http://journals.lww.com/10.1097/01.HS9.0000967844.56791.ba.  , 2023
Link: https://doi.org/10.1097/..
 
?
13

Use of 2,6-diaminopurine as a potent suppressor of UGA prem..:

Leroy, Catherine ; Spelier, Sacha ; Essonghe, Nadège Charlene...
1525-0016.  , 2023
Link: https://dspace.library.u..
 
?
14

Axicabtagene ciloleucel as second-line therapy in large B c..:

Houot, Roch ; Bachy, Emmanuel ; Cartron, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02572-5.  , 2023
Link: https://hal.science/hal-..
 
?
15

Axicabtagene ciloleucel as second-line therapy in large B c..:

Houot, Roch ; Bachy, Emmanuel ; Cartron, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02572-5.  , 2023
Link: https://hal.science/hal-..
 
1-15